Promising Rabies Vaccine for Postexposure Prophylaxis in Developing Countries, a Purified Vero Cell Vaccine Produced in China-Reference-Cited by-同舟云学术

Promising Rabies Vaccine for Postexposure Prophylaxis in Developing Countries, a Purified Vero Cell Vaccine Produced in China

Published:2010-04 Issue:4 Volume:17 Page:688-690
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin Vaccine Immunol

Author:

Wang Chuanlin¹²³⁴,Zhang Xiaowei¹²³⁴,Song Qingkun¹²³⁴,Tang Kun¹²³⁴

Affiliation:

1. Emergency Department, Peking University People's Hospital, Beijing, China

2. Urology Department, Peking University People's Hospital, Beijing, China

3. Department of Public Health, Chinese University of Hong Kong, Hong Kong

4. Department of Global Health and Population, Harvard University School of Public Health, Boston, Massachusetts

Abstract

ABSTRACT We evaluated the immunogenicity, safety, and antibody persistence of a Vero cell rabies vaccine manufactured in China, compared with those of Verorab. Adequate titers of antibody were observed for the two vaccines. ChengDa rabies vaccine could be a promising alternative vaccine for many developing countries which cannot afford expensive rabies vaccines.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://journals.asm.org/doi/pdf/10.1128/CVI.00433-09

Reference10 articles.

1. Cleaveland, S., M. Kaare, D. Knobel, and M. K. Laurenson. 2006. Canine vaccination—providing broader benefits for disease control. Vet. Microbiol.117:43-50.

2. Coulibaly, N. D., and K. R. Yameogo. 2000. Prevalence and control of zoonotic diseases: collaboration between public health workers and veterinarians in Burkina Faso. Acta Trop.76:53-57.

3. Dodet, B. 2006. Preventing the incurable: Asian rabies experts advocate rabies control. Vaccine24:3045-3049.

4. Kihm, U., A. Flamand, P. P. Pastoret, and E. Peterhans. 1992. Round table on epidemiology and control of fox rabies. Vet. Microbiol.33:297-301.

5. Lin, F. T., and N. Lina. 2000. Developments in the production and application of rabies vaccine for human use in China. Trop. Doct.30:14-16.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures;Vaccines;2023-08-01

2. Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial;Human Vaccines & Immunotherapeutics;2021-02-25

3. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects;Human Vaccines & Immunotherapeutics;2017-03-31

4. Animal-Associated Exposure to Rabies Virus among Travelers, 1997–2012;Emerging Infectious Diseases;2015-04

5. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis;Expert Review of Vaccines;2014-10-15